Viewing Study NCT00652002


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-03-02 @ 5:12 AM
Study NCT ID: NCT00652002
Status: COMPLETED
Last Update Posted: 2011-01-24
First Post: 2008-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module